Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China.
Zhang YY, Huang HH, Ren ZY, Zheng HG, Yu YS, Lü XJ, Xiao ZK, Yang HF, Xiu QY, Chen BY, Yue HM, Hao QL, Huang JA, Ma H, Xiao W, Guo DY, Si B, Sun SH, Zhang W, Li QH, Shen HH, Duan J, Li HY, Yao WZ, Gu JM, Xia QM, Ying KJ, Liu A, Yang HP, Shi MH, Sun TY, Ding GH, Wu GM.
Zhang YY, et al. Among authors: si b.
J Infect Chemother. 2009 Oct;15(5):301-11. doi: 10.1007/s10156-009-0713-9. Epub 2009 Oct 24.
J Infect Chemother. 2009.
PMID: 19856068
Clinical Trial.